Outcomes of Maintenance Immunotherapy in a Cohort of Patients With Susac Syndrome
Our relatively large cohort of patients with SuS shows a variety of maintenance immunotherapies are used with varying response rates. Among our patients, a number of refractory cases required aggressive and combination of immunotherapies.
Authors
- Abdul-Rahman Salman (ORCID: https://orcid.org/0000-0003-0255-451X)
- Natthapon Rattanathamsakul (ORCID: https://orcid.org/0000-0002-1698-0520)
- Bart K. Chwalisz (ORCID: https://orcid.org/0000-0001-9918-1742)
- Aditi Varma-Doyle
- Negar Moheb (ORCID: https://orcid.org/0000-0002-9573-5207)
- Deena Tajfirouz (ORCID: https://orcid.org/0000-0001-8419-8728)
- Andrew B. McKeon (ORCID: https://orcid.org/0000-0001-6856-8143)
- Kevin D. Chodnicki (ORCID: https://orcid.org/0000-0002-6815-8272)
- Leigh A. Rettenmaier (ORCID: https://orcid.org/0000-0003-0895-0388)
- John Jing-Wei Chen (ORCID: https://orcid.org/0000-0003-3644-7528)
Institutions
- Massachusetts Eye and Ear Infirmary (US)
- Lehigh Valley Hospital-Pocono (US)
- Harvard University (US)
- George Washington University (US)
- Massachusetts General Hospital (US)
- Mayo Clinic in Arizona (US)
Publication Details
- Journal
- Neurology Clinical Practice
- Published
- 2025-10-02
- DOI
- https://doi.org/10.1212/cpj.0000000000200544
- Citations
- 2
- Primary Topic
- Retinal and Optic Conditions
- Type
- article
- Field-Weighted Citation Impact
- 3.41